Literature DB >> 6223079

Cells in murine fetal liver and in lymphoid colonies grown from fetal liver can suppress generation of cytotoxic T lymphocytes directed against their self antigens.

S Muraoka, R G Miller.   

Abstract

Fetal liver (FL) cells or, in much smaller numbers, cells in lymphoid colonies grown from FL of mouse strain A can suppress the development of cytotoxic activity in a B anti-A mixed lymphocyte reaction (MLR) but not a B anti-C MLR. A, B, and C represent three H-2 different mouse strains. Suppressor cells with similar properties have been described in thymus, bone marrow, lymphoid colonies grown from bone marrow, and athymic nude spleen. They have been referred to collectively as "veto cells". From the point of view of the suppressor cells, a response against self is being suppressed. The FL colony suppressor cells differ from those described in that they can sometimes also suppress an A anti-B response. The FL colony suppressor cells are Thy-1- and resistant to 1500 rad irradiation. These cells may play a role in maintenance of self tolerance. That they are found in FL as early as 13 days of gestation implies that potentially self-reactive cells may develop before experiencing the thymus environment.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6223079

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  AKR.H-2b lymphocytes inhibit the secondary in vitro cytotoxic T-lymphocyte response of primed responder cells to AKR/Gross murine leukemia virus-induced tumor cell stimulation.

Authors:  R F Rich; W R Green
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

2.  Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. I. CTL clones express strong anti-self suppressive activity.

Authors:  M H Claësson; R G Miller
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307

3.  A strategy to protect off-the-shelf cell therapy products using virus-specific T-cells engineered to eliminate alloreactive T-cells.

Authors:  David H Quach; Luis Becerra-Dominguez; Rayne H Rouce; Cliona M Rooney
Journal:  J Transl Med       Date:  2019-07-24       Impact factor: 5.531

4.  The use of donor-derived veto cells in hematopoietic stem cell transplantation.

Authors:  Eran Ophir; Yair Reisner
Journal:  Front Immunol       Date:  2012-05-02       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.